BioCentury
ARTICLE | Finance

Agendia's agenda

Dutch diagnostics play Agendia plans to raise up to EUR 75M in IPO

June 13, 2011 7:00 AM UTC

Molecular diagnostics play Agendia B.V. expects to start trading on June 21 on NYSE Euronext in Amsterdam. It hopes to raise up to €75 million ($109.6 million) through the sale of up to 4.6 million shares at €16.35-€19.15 in the IPO.

Agendia said the proposed price range would give it a market cap of about €225-€250 million ($329-$365 million)...